Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection

Go back to Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection
(NASDAQ: ADTX) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High
Open $0.01    52 Week Low
Day High $0.01    P/E N/A 
Day Low $0.01    EPS
Volume 110,056,537